Position 5-7: Finalization

Central Artery

Select the specific approach and device combination to identify the exact billable procedure code.

Approach 0

Open

Device 0

3E06002 Introduction Central Artery to High-dose Interleukin-2 with Antineoplastic, Open Approach
3E06003 Introduction Central Artery to Low-dose Interleukin-2 with Antineoplastic, Open Approach
3E06005 Introduction Central Artery to Other Antineoplastic with Antineoplastic, Open Approach
3E0600M Introduction Central Artery to Monoclonal Antibody with Antineoplastic, Open Approach
3E0600P Introduction Central Artery to Clofarabine with Antineoplastic, Open Approach

Device 1

3E06016 Introduction Central Artery to Recombinant Human-activated Protein C with Thrombolytic, Open Approach
3E06017 Introduction Central Artery to Other Thrombolytic with Thrombolytic, Open Approach

Device 2

3E06028 Introduction Central Artery to Oxazolidinones with Anti-infective, Open Approach
3E06029 Introduction Central Artery to Other Anti-infective with Anti-infective, Open Approach

Device 3

3E0603Z Introduction Central Artery to No Qualifier with Anti-inflammatory, Open Approach

Device 4

3E0604Z Introduction Central Artery to No Qualifier with Serum, Toxoid and Vaccine, Open Approach

Device 6

3E0606Z Introduction Central Artery to No Qualifier with Nutritional Substance, Open Approach

Device 7

3E0607Z Introduction Central Artery to No Qualifier with Electrolytic and Water Balance Substance, Open Approach

Device F

3E060FZ Introduction Central Artery to No Qualifier with Intracirculatory Anesthetic, Open Approach

Device G

3E060GC Introduction Central Artery to Other Substance with Other Therapeutic Substance, Open Approach
3E060GN Introduction Central Artery to Blood Brain Barrier Disruption with Other Therapeutic Substance, Open Approach

Device H

3E060HZ Introduction Central Artery to No Qualifier with Radioactive Substance, Open Approach

Device K

3E060KZ Introduction Central Artery to No Qualifier with Other Diagnostic Substance, Open Approach

Device N

3E060NZ Introduction Central Artery to No Qualifier with Analgesics, Hypnotics, Sedatives, Open Approach

Device P

3E060PZ Introduction Central Artery to No Qualifier with Platelet Inhibitor, Open Approach

Device R

3E060RZ Introduction Central Artery to No Qualifier with Antiarrhythmic, Open Approach

Device T

3E060TZ Introduction Central Artery to No Qualifier with Destructive Agent, Open Approach

Device V

3E060VG Introduction Central Artery to Insulin with Hormone, Open Approach
3E060VH Introduction Central Artery to Human B-type Natriuretic Peptide with Hormone, Open Approach
3E060VJ Introduction Central Artery to Other Hormone with Hormone, Open Approach

Device W

3E060WK Introduction Central Artery to Immunostimulator with Immunotherapeutic, Open Approach
3E060WL Introduction Central Artery to Immunosuppressive with Immunotherapeutic, Open Approach

Device X

3E060XZ Introduction Central Artery to No Qualifier with Vasopressor, Open Approach
Approach 3

Percutaneous

Device 0

3E06302 Introduction Central Artery to High-dose Interleukin-2 with Antineoplastic, Percutaneous Approach
3E06303 Introduction Central Artery to Low-dose Interleukin-2 with Antineoplastic, Percutaneous Approach
3E06305 Introduction Central Artery to Other Antineoplastic with Antineoplastic, Percutaneous Approach
3E0630M Introduction Central Artery to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
3E0630P Introduction Central Artery to Clofarabine with Antineoplastic, Percutaneous Approach

Device 1

3E06316 Introduction Central Artery to Recombinant Human-activated Protein C with Thrombolytic, Percutaneous Approach
3E06317 Introduction Central Artery to Other Thrombolytic with Thrombolytic, Percutaneous Approach

Device 2

3E06328 Introduction Central Artery to Oxazolidinones with Anti-infective, Percutaneous Approach
3E06329 Introduction Central Artery to Other Anti-infective with Anti-infective, Percutaneous Approach

Device 3

3E0633Z Introduction Central Artery to No Qualifier with Anti-inflammatory, Percutaneous Approach

Device 4

3E0634Z Introduction Central Artery to No Qualifier with Serum, Toxoid and Vaccine, Percutaneous Approach

Device 6

3E0636Z Introduction Central Artery to No Qualifier with Nutritional Substance, Percutaneous Approach

Device 7

3E0637Z Introduction Central Artery to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach

Device F

3E063FZ Introduction Central Artery to No Qualifier with Intracirculatory Anesthetic, Percutaneous Approach

Device G

3E063GC Introduction Central Artery to Other Substance with Other Therapeutic Substance, Percutaneous Approach
3E063GN Introduction Central Artery to Blood Brain Barrier Disruption with Other Therapeutic Substance, Percutaneous Approach

Device H

3E063HZ Introduction Central Artery to No Qualifier with Radioactive Substance, Percutaneous Approach

Device K

3E063KZ Introduction Central Artery to No Qualifier with Other Diagnostic Substance, Percutaneous Approach

Device N

3E063NZ Introduction Central Artery to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach

Device P

3E063PZ Introduction Central Artery to No Qualifier with Platelet Inhibitor, Percutaneous Approach

Device R

3E063RZ Introduction Central Artery to No Qualifier with Antiarrhythmic, Percutaneous Approach

Device T

3E063TZ Introduction Central Artery to No Qualifier with Destructive Agent, Percutaneous Approach

Device V

3E063VG Introduction Central Artery to Insulin with Hormone, Percutaneous Approach
3E063VH Introduction Central Artery to Human B-type Natriuretic Peptide with Hormone, Percutaneous Approach
3E063VJ Introduction Central Artery to Other Hormone with Hormone, Percutaneous Approach

Device W

3E063WK Introduction Central Artery to Immunostimulator with Immunotherapeutic, Percutaneous Approach
3E063WL Introduction Central Artery to Immunosuppressive with Immunotherapeutic, Percutaneous Approach

Device X

3E063XZ Introduction Central Artery to No Qualifier with Vasopressor, Percutaneous Approach